VUFB 15496

Drug Profile

VUFB 15496

Alternative Names: Cloflumide

Latest Information Update: 14 Apr 2010

Price : $50

At a glance

  • Originator VUFB
  • Developer Zentiva
  • Class Antipsychotics
  • Mechanism of Action Dopamine receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 13 Feb 2001 Suspended-Preclinical for Psychotic disorders in Czech Republic (Unknown route)
  • 10 Feb 1997 No-Development-Reported for Psychotic disorders in Czech Republic (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top